ACE2 and COVID-19: It also enhances the viral loads of upper respiratory tract and the binding and fusion of ACE2 in patients with COVID-19, which increased the spread of SARS-CoV-2 virus, resulting in the enhancement of the replication of human lung epithelial cells and primary human airway tissues as shown in Fig. 4B.